Comparison of Nasal Endotracheal Tube and Spiral Tube for Nasotracheal Intubation in Pediatric Patients
Launched by DICLE UNIVERSITY · May 14, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different types of tubes used for a procedure called nasotracheal intubation in children who are having dental surgery under general anesthesia. The goal is to compare a standard spiral tube with a specially designed nasal tube called the North Polar Tube. Researchers want to find out which tube is better in terms of how often it causes nosebleeds (epistaxis), how long it takes to insert, and how easy or difficult the insertion process is.
To participate in this study, children must be between the ages of 3 and 18 and must not have any facial issues that would make nasal intubation difficult. Parents or guardians need to give their consent for their child to join. Participants can expect that their experience will be closely monitored during the procedure, and the findings from this study may help improve the care provided to children needing this type of intubation in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being between 3-18 years old
- • No anomaly preventing nasal intubation
- • To be in ASA1-2 classification according to ASA criteria
- Exclusion Criteria:
- • Lack of consent of the patient/ relatives
- • Facial anomaly that prevents nasal intubation
- • Being in the ASA3-4 group according to ASA criteria
About Dicle University
Dicle University is a prominent academic institution located in the southeastern region of Turkey, dedicated to advancing medical research and education. With a strong commitment to improving healthcare outcomes, Dicle University actively sponsors clinical trials that aim to explore innovative treatments and enhance patient care. The university's multidisciplinary approach fosters collaboration among researchers, healthcare professionals, and students, ensuring that clinical studies are conducted with rigor and integrity. Through its clinical trial initiatives, Dicle University strives to contribute valuable insights to the scientific community and support the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Diyarbakir, , Turkey
Patients applied
Trial Officials
Fikret Salik, specialist
Study Director
Dicle university faculty of medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported